Health_Whirl

Influenza, also known as a flu, is a common viral infection that affects the respiratory system. The major three types of influenza viruses impacting humans are Type A, Type B, and Type C. The fourth form of influenza virus, known as Type D, does not affect the humans, but is considered to have the potential to do so. The common symptoms of influenza include sneezing, high fever, running nose, headache, coughing, sore throat, joint pains, and feeling tired. Furthermore, diarrhea and vomiting are the additional symptoms observed in children. Influenza vaccine, also known as flu shot or flu jabs, is used as a protection against influenza virus. Newer versions of influenza vaccines are developed twice a year owing to the rapid changes in the influenza virus. The effectiveness of these vaccines varies year to year, but are known to offer moderate to high protection against influenza. Request the Coronavirus Impact Analysis on this Markets –   https://www.transpa...

The vendor landscape of the  global reprocessed medical devices market  is significantly consolidated with the leading few companies collectively accounting for a lion’s share in the overall market, observes Transparency Market Research in a recent report. The leading five companies in the market, namely Vanguard AG, Hygia Health Services Inc., Stryker Sustainability Solutions, Medline Industries Inc., and Ethicon (a subsidiary of Johnson & Johnson) held a nearly 94% share in the market in 2015. To gain better growth opportunities in this highly consolidated market, which has kept small and new companies at bay owing to the vast regulations and requirements that need to be followed for ensuring that the safety and reliability of reprocessing practices is without error, established companies are exploring new regional markets with untapped growth opportunities. As such, companies are moving their focus towards regions such as Latin America and Asia Pacific wher...

The  global gynecological devices market  is marked by a high degree of fragmentation due to the presence of several large and small manufacturers, reports Transparency Market Research (TMR) in a new business intelligence study. This leaves ample room for market consolidation in the near future. Nevertheless, top companies namely Boston Scientific Corporation, Cooper Surgical, and Olympus Corporation hold prominence on account of their extensive product portfolio and geographical outreach. These companies are vying to introduce non-invasive devices to serve a larger consumer base that will also help expand their geographical outreach. With increasing demand for medical help for women-centric health issues, there lies immense scope of growth for players in the gynecological devices market. At present, small as well as regional players hold significant share in the gynecological devices market. However, increasing entry barriers and stringent regulations for product approva...

The demand within the global market for intraocular lenses has been rising on account of the rising cases of cataract across the world, finds Transparency Market Research (TMR). The market vendors in the global  intraocular lenses market  have been making ardent effort to provide seamless services to the consumers. Intraocular lenses are used during cataract surgeries, and hence, it is immensely important to ensure high standards of production and quality. The market vendors in the global intraocular lenses market have taken an onus upon themselves to produce high quality lenses. Furthermore, these vendors have formed alliances with manufacturers of other eye-treatment products in recent times. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2170 It is expected that the leading vendors in the global intraocular lenses market would capitalise on improving the quality of their lenses. Moreover, acqu...

The  wound healing market  is expected to witness robust growth in the near future, as rising number of accidents, and increasing access to healthcare fuels growth. The market will likely rise to US$35,065.7 mn in evaluation by the end of 2025, rising at 4.80% CAGR. Advanced wound care is likely to drive robust growth in developed countries, due to major increases in chronic illnesses, and advanced technology. Among applications, the hemostatic agents are likely to witness robust growth as cases of accidents, chronic illnesses, and advancements in products drive growth. Rising number of diabetics will also promise new opportunities for players in the wound healing market. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40535 Among regions, Asia Pacific will drive robust growth for the wound healing market. The region is home to large number of accidents, and currently witnessing an expansion of pri...

The  wound healing market  is expected to witness robust growth in the near future, as rising number of accidents, and increasing access to healthcare fuels growth. The market will likely rise to US$35,065.7 mn in evaluation by the end of 2025, rising at 4.80% CAGR. Advanced wound care is likely to drive robust growth in developed countries, due to major increases in chronic illnesses, and advanced technology. Among applications, the hemostatic agents are likely to witness robust growth as cases of accidents, chronic illnesses, and advancements in products drive growth. Rising number of diabetics will also promise new opportunities for players in the wound healing market. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40535 Among regions, Asia Pacific will drive robust growth for the wound healing market. The region is home to large number of accidents, and currently witnessing an expansion of p...

According to the report, the global  breast imaging market  was valued at ~ US$ 3.5 Bn  in  2019  and is projected to expand at a CAGR of ~ 8%  from 2020 to  2028 . Breast imaging products are used by healthcare professionals, especially by radiologists and oncology hospital technicians, for the diagnosis of breast cancer and monitoring of breast cancer therapy. Different types of technologies used for diagnosis of breast cancer include ionizing breast imaging and nonionizing breast imaging. The growth of the global breast imaging market can be attributed to the rise in number of people with breast cancer and increase in government initiatives. North America dominated the global breast imaging market in  2019,  and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early new product adoption, high penetration rate for breast imaging products, and presence of major players are expected to ...

The global  hip replacement implants market  was valued at approximately US$ 7.0 Bn in 2017. It is projected to register a cumulative annual growth rate (CAGR) of over 3.5% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘ Hip Replacement Implants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’  Expansion of the health care industry, government initiatives, increase in health care expenditure, rise in product approvals, and increase in the patient population are projected to augment the global market from 2018 to 2026. As key players introduce their new hip replacement implants in developed regions such a North America and Western Europe, these regions are likely to account for a dominating share of the global hip replacement implants market. Development of health care infrastructure and high medical expenditure by governments in emerging markets such as...

The vendor landscape in the  global dental prosthetics market  demonstrates a relatively consolidated structure, states a new report by Transparency Market Research (TMR). The top three players namely, Institut Straumann AG, DENTSPLY International Inc., and Nobel Biocare Holdings AG, held 48.5% of the overall market in 2014. These players are actively involved into collaborative strategies, focusing especially towards developed economies with advanced healthcare infrastructure. The market, however, is equally captured by regional players, making the competition intense and, with the high influx of new players in the market, the scenario is likely to remain so over the next few years, states the research study. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=556 According to the research report, the global market for dental prosthetics, which stood at US$3.5 bn in 2016, is anticipated to expand at ...

The global prefilled syringes market displays a fragmented vendor landscape with the presence of several mid-size and large players, says Transparency Market Research (TMR) in a new report. In this competitive market, savvy players are using improved materials to improve the quality of syringe, and to improve manufacturing processes that can help boost production volume, adds the report. In addition, the focus of these players is to monitor the production process, and make the necessary changes, so as to ensure the right amount of drugs are filled in syringes. Such initiatives are likely to help keen players make a mark in the global prefilled syringes market. Top companies operating in the  global prefilled syringes market  are Stevanato Group, Baxter International, Unilife Corporation, West Pharmaceuticals, and Becton Dickinson & Co. According to the TMR report, the global prefilled syringes market is predicted to expand at a CAGR of 9.3% between 2016 and 2014 vis-...

The  global biologics market  has been displaying an aggressive competition divided among a handful of household organizations and a decent count of world’s best pharmaceutical companies. You could see such players competing among themselves to win an offer in this highly productive market. Transparency Market Research (TMR) has foreseen top players to upgrade their product portfolios with the help of bargains and co-improvement exercises as they get involved in strategic mergers and acquisitions. Players have also been observed to grow their assembling units and services across the globe. Biologics has witnessed billions of dollars put in by pharmaceutical behemoths such as AstraZenca, Novartis, and Eli Lilly and Co. If the expected CAGR of 10.9% holds true for the global biologics market between 2016 and 2024, the revenue valuation could ascend to a US$479.7 bn by the end of the forecast tenure, as per a TMR report. In 2017, the market had paraded a valuation of US$...

Transparency Market Research (TMR) has published a new report titled,  “Gene Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.  According to the report, the  global gene therapy market  was valued at US$ 17.0 Mn in 2017 and is projected to expand at a CAGR of 40.0% from 2018 to 2026. New product approvals, promising therapeutic outcomes of gene therapy, and high prevalence of non-Hodgkin Lymphoma are anticipated to drive the global market in the next few years. Europe is projected to dominate the global gene therapy market, followed by U.S., by the end of 2026. Potential unmet needs in the fields of oncology, rare genetic disorders in the U.S. and Europe, new product approvals and commercialization, and high clinical R&D budgets are likely to drive the gene therapy market in these regions during the forecast period. The gene therapy market in Rest of World is projected to expand at a significant CAGR during ...

The  global organ transplant immunosuppressant drugs market  depicts the presence of a highly consolidated vendor landscape, observes Transparency Market Research on the basis of a newly published report. Such a consolidated position mainly exists due to a handful of players working in the market as of current times. However, with new players entering the market on a regular basis, the vendor landscape is expected to become substantially fragmented in the next few years. Request Sample Of Report –   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1967 Participating in mergers & acquisitions, collaborations, and expanding product portfolios are key strategies implemented by most players working in the global organ transplant immunosuppressant drugs market. Many vendors face the risk of shutting down owing to expiry of drug patents they own. However, most of these companies are finding out alternatives such as coming up with new...

According to Transparency Market Research’s latest report on the global autologous cell therapy market for the historical period  2017–2018  and forecast period  2019–2027 , Rise in prevalence of autoimmune disorders, cancer, blood related disorders, are projected to drive the global autologous cell therapy market during the forecast period According to the report, the global autologous cell therapy market was valued at  US$ 7.5 Bn  in  2018  and is anticipated to expand at a CAGR of  18.1%  from  2019  to  2027 To know the scope of our report  Get a Sample  on Autologous Cell Therapy Market Rise in Prevalence of Autoimmune Disorders, Cancer, Neurodegenerative Disease Increase the Demand of Autologous cell therapy: Key Drivers The global autologous cell therapy market continues to expand at a high growth rate due to increasing prevalence of  autoimmune diseases , cancer orthopedic disorders. According t...

According to Transparency Market Research’s latest report on the global High Potency Active Pharmaceutical Ingredients (HPAPI) market for the historical period  2017–2018  and forecast period  2019–2027,  growing preference for outsourcing of HPAPI manufacturing and rich pipeline with targeted therapeutic drugs are the factors likely to boost the growth of High Potency Active Pharmaceutical Ingredients (HPAPI) market. However, containment of technical expertise in the hands of few major players and lack of universal regulatory policies and standards is poised to escalate the growth of High Potency Active Pharmaceutical Ingredients (HPAPI) market. According to the report, the global High Potency Active Pharmaceutical Ingredients (HPAPI) market was valued at  US$ 17.45 Bn  in  2018  and is anticipated to expand at a CAGR of over  8.7%  from  2019  to  2027 Request the Coronavirus Impact Analysis on this Markets -  ...

According to Transparency Market Research’s latest report on the global sterilization equipment and disinfectant market for the historical period  2017–2018  and forecast period  2019–2027 , high incidence & prevalence of infectious diseases and demand for safety of healthcare providers are projected to escalate the growth of global sterilization equipment and disinfectant market. According to the report, the global sterilization equipment and disinfectant market was valued at  US$ 5.3 Bn  in  2018  and is anticipated to expand at a CAGR of  7.6%  from  2019  to  2027 To know the scope of our report  Get a Sample  on Sterilization Equipment and Disinfectant Market Rise in Number of Surgeries and Increase in Prevalence of Chronic Diseases: Key Drivers of Global Sterilization Equipment and Disinfectant Market Changing lifestyle has propelled the incidence rate of various lifestyle diseases such as cancer...